W. Doss

G. Esmat, W. Doss, M. Hassany, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective.

W. Doss, G. Ragab, R. Barsoum, 2016, Journal of advanced research.

Hepatitis C virus: Efficacy of new DAAs Regimens.

W. Doss, S. Abd-Elsalam, Mahmoud Elkadeem, 2020, Infectious disorders drug targets.

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt

G. Shiha, I. Waked, G. Esmat, 2018, Gut.

Strategies to manage hepatitis C virus (HCV) disease burden

M. Buti, R. Marinho, T. Berg, 2014, Journal of viral hepatitis.

Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B

W. Doss, M. Hassany, S. Hamdy, 2022, Egyptian Liver Journal.

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes

I. Kabbash, G. Esmat, W. Doss, 2018, American journal of therapeutics.

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.

I. Waked, G. Esmat, W. Doss, 2017, Journal of hepatology.

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.

G. Shiha, G. Esmat, W. Doss, 2015, Journal of hepatology.

How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries

Y. Yazdanpanah, A. Mostafa, A. Fontanet, 2015, Hepatology.

Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.

M. Buti, U. Siebert, Y. Yazdanpanah, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results

W. Doss, M. Alboraie, H. Omar, 2019, Journal of medical virology.

Erectile dysfunction in patients with chronic hepatitis C virus infection.

W. Doss, S. Hunter, A. Gadallah, 2014, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Serum angiopoietin-2 as a noninvasive diagnostic marker of stages of liver fibrosis in chronic hepatitis C patients

W. Doss, S. Saleh, W. Yousry, 2016 .

Association Analysis of Genetic Variants of Sodium Taurocholate Co-Transporting Polypeptide NTCP Gene (SLC10A1) and HBV Infection Status in a Cohort of Egyptian Patients

V. Uversky, W. Doss, M. Hassany, 2021, Gastroenterology Insights.

Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience

W. Elakel, G. Esmat, W. Doss, 2022, Egyptian Liver Journal.

Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study

W. Doss, Y. Elshazly, M. El-Sayed, 2022, The Egyptian Journal of Internal Medicine.

Liver Fibrosis as a Predictive Factor of Response to Pegylated-IFN/ Ribavirin Therapy in Chronic HCV Patients

M. Saber, G. Esmat, W. Doss, 2021 .

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

I. Waked, W. Elakel, G. Esmat, 2019, Expert review of gastroenterology & hepatology.

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

I. Waked, G. Esmat, W. Doss, 2017, Journal of viral hepatitis.

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis

I. Waked, W. Doss, M. Hassany, 2017, Journal of viral hepatitis.

Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience

G. Esmat, W. Doss, Mahmoud Khalil, 2021, Expert review of anti-infective therapy.

One step closer to elimination of hepatitis C in Egypt.

I. Waked, G. Esmat, W. Doss, 2018, The lancet. Gastroenterology & hepatology.

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

T. Asselah, G. Shiha, I. Waked, 2016, The lancet. Gastroenterology & hepatology.

Cost Minimization of Pre-Enrolment Investigations in Treating HCV Infected Patients

W. Elakel, G. Esmat, W. Doss, 2020, The Egyptian Journal of Community Medicine.

Utility of telemedicine in the treatment of patients with chronic HCV infection using DAAs in remote areas with limited resources

I. Waked, W. Doss, M. Alboraie, 2021, Liver international : official journal of the International Association for the Study of the Liver.

The interrelation between lipid profile in chronic HCV patients and their response to antiviral agents

G. Esmat, W. Doss, M. Hassany, 2020, Expert review of gastroenterology & hepatology.

Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.

W. Doss, A. Zeid, S. Maklad, 2014, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Screening and Treatment Program to Eliminate Hepatitis C in Egypt.

I. Waked, G. Esmat, W. Doss, 2020, The New England journal of medicine.

Historical epidemiology of hepatitis C virus (HCV) in selected countries

M. Buti, R. Marinho, T. Berg, 2014, Journal of viral hepatitis.

The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

G. Shiha, I. Waked, G. Esmat, 2022, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients

W. Doss, M. Mabrouk, T. Awad, 2018, European journal of gastroenterology & hepatology.

Occult hepatitis B in Egyptian thalassemic children.

W. Doss, O. Shaker, A. Ahmed, 2012, Journal of infection in developing countries.

Response and seroconversion rates among HBeAg-positive chronic HBV Egyptian patients treated with peginterferon alpha 2a (Pegasys), a single-centre experience.

W. Doss, G. Esmat, S. Maklad, 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations.

M. Jadoul, K. Kalantar-Zadeh, G. Ashuntantang, 2020, African journal of nephrology : official publication of the African Association of Nephrology. African Association of Nephrology.

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

I. Waked, G. Esmat, W. Doss, 2019, Expert review of gastroenterology & hepatology.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

G. Esmat, E. Gower, M. Buti, 2014, Journal of viral hepatitis.

The case for simplifying and using absolute targets for viral hepatitis elimination goals

R. Malekzadeh, C. Richter, Chien-Jen Chen, 2020, Journal of viral hepatitis.

THU-137-DAA therapy in women of child bearing age: Accidental conception during therapy and pregnancy outcome

W. Doss, A. Elsharkawy, M. El-Sayed, 2019, Journal of Hepatology.

Intestinal capillariass in Egypt epideiologigal background.

W. Doss, N. El-Dib, 2002, Journal of the Egyptian Society of Parasitology.

Fibroscan of chronic HCV patients coinfected with schistosomiasis.

M. Mohamed, G. Esmat, W. Doss, 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools.

W. Doss, M. Hassany, T. Essam, 2022, The lancet. Gastroenterology & hepatology.

Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.

M. Abdel-hamid, R. Breban, A. Mostafa, 2014, The Lancet. Global health.

Quantifying current hepatitis C virus incidence in Egypt – Response to letter by Miller and Abu‐Raddad

R. Breban, A. Fontanet, M. Mohamed, 2013, Journal of viral hepatitis.

Low Serum Alpha-fetoprotein Level an Important Predictor for Therapeutic Outcome in Egyptian Patients with Chronic Hepatitis C: A Data-Mining Analysis

W. Doss, M. Mabrouk, N. Zayed, 2014 .

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.

B. Kasiske, V. Jha, P. Patel, 2018, Kidney international.

Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4

D. Saleh, W. Doss, A. Ahmed, 2013, European journal of gastroenterology & hepatology.

Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study.

W. Doss, S. Zaky, F. El-Raey, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.

Gamal Esmat, Adeline Bernier, A. Fontanet, 2012, MMWR. Morbidity and mortality weekly report.

Acute variceal hemorrhage: The persistent bleeder. A plea for management

W. Doss, M. Saad, F. Thakeb, 1994, World Journal of Surgery.

Efﬁcacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience

W. Elakel, W. Doss, Mai Mehrez, 2018, Journal of medical virology.

Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis

I. Waked, G. Esmat, W. Doss, 2016 .

Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt.

I. Waked, W. Elakel, G. Esmat, 2022, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Quality of life of Egyptian donors after living-related liver transplantation.

G. Esmat, W. Doss, A. Yosry, 2009, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

G. Esmat, W. Doss, A. Yosry, 2012, Annals of hepatology.

G. Esmat, W. Doss, A. Yosry, 2012 .

The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patients

H. Wedemeyer, M. Said, W. Elakel, 2018, Alimentary pharmacology & therapeutics.

Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma

I. Waked, W. Doss, M. Hassany, 2021, Expert review of anti-infective therapy.

Ombitasvir/Paritaprevir/Ritonavir with Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egyptian Adults with Chronic HCV Genotype 4 Infection (Agate-II)

G. Shiha, I. Waked, G. Esmat, 2016 .

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients

W. Doss, N. Morcos, E. Saleh, 2022, Egyptian Journal of Pure and Applied Science.

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline

B. Kasiske, V. Jha, P. Patel, 2019, Annals of Internal Medicine.

Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens

G. Esmat, W. Doss, Hend A. Mahmoud, 2020, European journal of gastroenterology & hepatology.

Pregnancy outcome of anti‐HCV direct‐acting antivirals: Real‐life data from an Egyptian cohort

G. Esmat, W. Doss, M. Hassany, 2021, Liver international (Print).

P1346 : Study protocol for a partly randomised, open-label phase IIA trial of once-daily simeprevir combined with sofosbuvir for the treatment of HCV genotype 4 infected patients with or without cirrhosis (OSIRIS)

M. Hashem, A. Gomaa, I. Waked, 2015 .

Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.

W. Elakel, W. Doss, Mai Mehrez, 2023, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.

B. Kasiske, V. Jha, P. Patel, 2018, Kidney international.

Fibroscan of chronic HCV patients coinfected with schistosomiasis.

M. Mohamed, G. Esmat, W. Doss, 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.

I. Waked, G. Esmat, W. Doss, 2017, Journal of hepatology.

Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.

G. Esmat, W. Doss, R. Tohme, 2012, MMWR. Morbidity and mortality weekly report.

Hepatitis C Virus in Egypt: Interim Report From the World’s Largest National Program

I. Waked, G. Esmat, W. Doss, 2019, Clinical liver disease.

Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4

D. Saleh, W. Doss, A. Ahmed, 2013, European journal of gastroenterology & hepatology.

Obesity prevalence in adults and patients with hepatitis C: results from screening a population of 50 million in Egypt

I. Waked, G. Esmat, W. Doss, 2024, Egyptian Liver Journal.

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

G. Esmat, W. Doss, M. Hassany, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Occult hepatitis B in Egyptian thalassemic children.

W. Doss, O. Shaker, A. Ahmed, 2012, Journal of infection in developing countries.